Other names published for TOP2: TOR3, TRF3, DNA topoisomerase 2, YNL088W
TOP2 LITERATURE TOPICS
- Curated Literature
- Genetics/Cell Biology
- Nucleic Acid Information
- Gene Product Information
- Related Genes/Proteins
- Research Aids
- Genome-wide Analysis
- Proteome-wide Analysis
- Other Topics
- Additional Information
TOP2 - Reviews (24)
| Reference | Other Genes Addressed |
|---|---|
| Carter SD and Sjogren C (2012) The SMC complexes, DNA and chromosome topology: right or knot? Crit Rev Biochem Mol Biol 47(1):1-16 | |
| Alver RC and Bielinsky AK (2010) Termination at sTop2. Mol Cell 39(4):487-489 | |
| Baxter J and Aragon L (2010) Physical linkages between sister chromatids and their removal during yeast chromosome segregation. Cold Spring Harb Symp Quant Biol 75():389-94 | |
| Lee MT and Bachant J (2009) SUMO Modification of DNA topoisomerase II: Trying to get a CENse of it all. DNA Repair (Amst) 8(4):557-68 | |
| Diaz-Martinez LA, et al. (2008) Chromosome cohesion - rings, knots, orcs and fellowship. J Cell Sci 121(Pt 13):2107-14 | |
| Watts FZ (2007) The role of SUMO in chromosome segregation. Chromosoma 116(1):15-20 | |
| Lee KM and O'Connell MJ (2006) A new SUMO ligase in the DNA damage response. DNA Repair (Amst) 5(1):138-41 | |
| Garcia V, et al. (2005) Identification and functional analysis of TopBP1 and its homologs. DNA Repair (Amst) 4(11):1227-39 | |
| Stemmann O, et al. (2005) Rephrasing anaphase: separase FEARs shugoshin. Chromosoma 113(8):409-17 | |
| Gadelle D, et al. (2003) Phylogenomics of type II DNA topoisomerases. Bioessays 25(3):232-42 | |
| Champoux JJ (2001) DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem 70():369-413 | |
| Vessey CJ, et al. (1999) Genetic disorders associated with cancer predisposition and genomic instability. Prog Nucleic Acid Res Mol Biol 63():189-221 | |
| Berger JM (1998) Structure of DNA topoisomerases. Biochim Biophys Acta 1400(1-3):3-18 | |
| Reid RJ, et al. (1998) Yeast as a model organism for studying the actions of DNA topoisomerase-targeted drugs. Biochim Biophys Acta 1400(1-3):289-300 | |
| Rybenkov VV, et al. (1997) Simplification of DNA topology below equilibrium values by type II topoisomerases. Science 277(5326):690-3 | |
| Nitiss JL, et al. (1996) Using yeast to understand drugs that target topoisomerases. Ann N Y Acad Sci 803():32-43 | |
| Wang JC (1996) DNA topoisomerases. Annu Rev Biochem 65:635-92 | |
| Klein HL (1995) Examination of mitotic recombination by means of hyper-recombination mutants in Saccharomyces cerevisiae. Prog Nucleic Acid Res Mol Biol 51:271-303 | |
| Roca J (1995) The mechanisms of DNA topoisomerases. Trends Biochem Sci 20(4):156-60 | |
| Vassetzky YS, et al. (1995) DNA topoisomerase II mutations and resistance to anti-tumor drugs. Bioessays 17(9):767-74 | |
| Chen AY and Liu LF (1994) Mechanisms of resistance to topoisomerase inhibitors. Cancer Treat Res 73():263-81 | |
| Nitiss JL (1994) Using yeast to study resistance to topoisomerase II-targeting drugs. Cancer Chemother Pharmacol 34 Suppl():S6-13 | |
| Beck WT, et al. (1993) Drug resistance associated with altered DNA topoisomerase II. Adv Enzyme Regul 33():113-27 | |
| Wang JC, et al. (1990) The role of DNA topoisomerases in recombination and genome stability: a double-edged sword? Cell 62(3):403-6 |



